These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 36873982)

  • 1. Vascular therapy for Duchenne muscular dystrophy (DMD).
    Thapa S; Elhadidy S; Asakura A
    Fac Rev; 2023; 12():3. PubMed ID: 36873982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis as a novel therapeutic strategy for Duchenne muscular dystrophy through decreased ischemia and increased satellite cells.
    Shimizu-Motohashi Y; Asakura A
    Front Physiol; 2014; 5():50. PubMed ID: 24600399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duchenne muscular dystrophy: pathogenesis and promising therapies.
    Chang M; Cai Y; Gao Z; Chen X; Liu B; Zhang C; Yu W; Cao Q; Shen Y; Yao X; Chen X; Sun H
    J Neurol; 2023 Aug; 270(8):3733-3749. PubMed ID: 37258941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular-targeted therapies for Duchenne muscular dystrophy.
    Ennen JP; Verma M; Asakura A
    Skelet Muscle; 2013 Apr; 3(1):9. PubMed ID: 23618411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.
    Siemionow M; Langa P; Harasymczuk M; Cwykiel J; Sielewicz M; Smieszek J; Heydemann A
    Stem Cells Transl Med; 2021 Oct; 10(10):1406-1418. PubMed ID: 34291884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multifaceted view of heart problem in Duchenne muscular dystrophy.
    Florczyk-Soluch U; Polak K; Dulak J
    Cell Mol Life Sci; 2021 Jul; 78(14):5447-5468. PubMed ID: 34091693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and emerging treatment strategies for Duchenne muscular dystrophy.
    Mah JK
    Neuropsychiatr Dis Treat; 2016; 12():1795-807. PubMed ID: 27524897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle.
    Klymiuk N; Blutke A; Graf A; Krause S; Burkhardt K; Wuensch A; Krebs S; Kessler B; Zakhartchenko V; Kurome M; Kemter E; Nagashima H; Schoser B; Herbach N; Blum H; Wanke R; Aartsma-Rus A; Thirion C; Lochmüller H; Walter MC; Wolf E
    Hum Mol Genet; 2013 Nov; 22(21):4368-82. PubMed ID: 23784375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying FDA-Approved Drugs that Upregulate Utrophin A as a Therapeutic Strategy for Duchenne Muscular Dystrophy.
    Péladeau C; Jasmin BJ
    Methods Mol Biol; 2023; 2587():495-510. PubMed ID: 36401046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting angiogenesis in Duchenne muscular dystrophy.
    Podkalicka P; Mucha O; Dulak J; Loboda A
    Cell Mol Life Sci; 2019 Apr; 76(8):1507-1528. PubMed ID: 30770952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empowering Muscle Stem Cells for the Treatment of Duchenne Muscular Dystrophy.
    Filippelli RL; Chang NC
    Cells Tissues Organs; 2022; 211(6):641-654. PubMed ID: 33910206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
    Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Application of Extracellular Vesicles-Capsulated Adeno-Associated Virus Vector via
    Matsuzaka Y; Hirai Y; Hashido K; Okada T
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle.
    Ebrahimi M; Lad H; Fusto A; Tiper Y; Datye A; Nguyen CT; Jacques E; Moyle LA; Nguyen T; Musgrave B; Chávez-Madero C; Bigot A; Chen C; Turner S; Stewart BA; Pegoraro E; Vitiello L; Gilbert PM
    Acta Biomater; 2021 Sep; 132():227-244. PubMed ID: 34048976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Sarathy A; Wuebbles RD; Fontelonga TM; Tarchione AR; Mathews Griner LA; Heredia DJ; Nunes AM; Duan S; Brewer PD; Van Ry T; Hennig GW; Gould TW; Dulcey AE; Wang A; Xu X; Chen CZ; Hu X; Zheng W; Southall N; Ferrer M; Marugan J; Burkin DJ
    Mol Ther; 2017 Jun; 25(6):1395-1407. PubMed ID: 28391962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
    Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.